Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act

This bill reauthorizes the federal loan repayment program for healthcare professionals working in substance use disorder treatment. It directly affects clinicians and providers by making loan repayments tax-free under the Internal Revenue Code and increasing annual funding from $25 million to $50 million for fiscal years 2024-2028. Key provisions include adding a tax exemption for repayment amounts (amending Section 781(b)(3)) and extending the program with higher funding levels. The changes aim to support workforce retention in a critical healthcare sector by reducing financial barriers for treatment professionals.